MediSpend Acquires Alucio to Expand AI-Enabled Stakeholder Engagement Capabilities

PORTSMOUTH, N.H., Aug. 4, 2025 /PRNewswire/ -- MediSpend, a global leading provider of compliance and stakeholder engagement solutions for the life sciences industry, announces its acquisition of Alucio, an innovative technology company known for its AI-enabled content management and HCP engagement platform, BEACON. The acquisition enhances MediSpend's offerings to support more effective scientific exchanges between life sciences companies and healthcare providers. This marks MediSpend's third acquisition in the past year and reinforces its commitment to delivering comprehensive, scalable solutions that meet the evolving needs of life sciences organizations worldwide.

Alucio's BEACON platform enables seamless and compliant content engagement across medical affairs, clinical affairs, and market access, empowering field teams to deliver dynamic, personalized scientific interactions with healthcare professionals (HCPs) and organizations. This strategic move supports MediSpend's ongoing mission to empower life sciences companies to grow their business compliantly while delivering more meaningful stakeholder interactions and insights.  

Driving Innovation with AI-Powered Scientific Engagement
Alucio brings advanced AI-powered capabilities that transform how medical affairs teams manage and share scientific information. By integrating artificial intelligence into content management and HCP engagement workflows, the MediSpend platform offers expanded functionality to personalize interactions, streamline content distribution and generate real-time insights. These enhancements support high-impact, compliant scientific exchange on a global scale.

"This acquisition brings valuable innovation into the MediSpend platform," said Leigh Powell, Executive Chairman of MediSpend. "With these added capabilities, we're strengthening our ability to support medical affairs teams with smarter tools for managing content and delivering compliant, high-quality scientific communications."

Delivering Value Across the Life Sciences Industry
By combining MediSpend's trusted compliance infrastructure with Alucio's AI-driven communication capabilities, clients gain a cohesive solution that supports compliant, efficient and insight-driven engagement across both commercial and medical teams. Clients will benefit from:

• Smarter Scientific Exchange: AI-assisted delivery enables tailored, compliant interactions between MSLs and HCPs.
• Seamless Content Management: Efficient tools for organizing, presenting and sharing scientific information that are designed to meet both internal needs and regulatory standards.  
• Actionable Analytics: Built-in intelligence provides visibility into engagement metrics and content performance, enabling teams to make data-driven decisions.

"We're excited to join MediSpend and expand the reach of our technology," said Dave Gulezian, CEO of Alucio. "Together, we'll deliver next-generation solutions that elevate how medical affairs teams communicate and engage with HCPs in a compliant manner."

Strengthening MediSpend's Leadership in Life Sciences Technology
The integration of BEACON into the MediSpend platform will create a seamless solution for life sciences companies seeking to unify compliance, transparency, and engagement functions—an increasingly critical need in today's complex regulatory environment.

About MediSpend
MediSpend's best-in-class solutions empower life sciences companies to grow their business compliantly through top-rated solutions and client services. MediSpend provides commercial compliance solutions for the largest pharmaceutical, medical device and dental companies as well as emerging biotech companies across the world. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands. Visit MediSpend online at www.medispend.com.

About Alucio
Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio's flagship product, Beacon, is a modern, AI-enabled scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company's website at http://www.alucio.io

Media Contact
Seth Houston
Chief Commercial Officer
MediSpend
Email: [email protected] 
Phone: +1 (215) 779-2415

View original content to download multimedia:https://www.prnewswire.com/news-releases/medispend-acquires-alucio-to-expand-ai-enabled-stakeholder-engagement-capabilities-302520772.html

SOURCE MediSpend